Title:
【発明の名称】CD20およびNOGO遺伝子発現の調節および診断のための方法および試薬
Document Type and Number:
Japanese Patent JP2003525037
Kind Code:
A
Abstract:
The present invention relates to nucleic acid molecules, including antisense and enzymatic nucleic acid molecules, such as hammerhead ribozymes, DNAzymes, and antisense, which modulate the expression of NOGO and NOGO receptor genes.
Inventors:
Brat, lawrence
Max Wigen, James
Tovey, Michael, Gerrard
Max Wigen, James
Tovey, Michael, Gerrard
Application Number:
JP2001558241A
Publication Date:
August 26, 2003
Filing Date:
February 09, 2001
Export Citation:
Assignee:
Ribozyme Pharmaceuticals Incorporated
Brat, lawrence
Max Wigen, James
Tovey, Michael, Gerrard
Brat, lawrence
Max Wigen, James
Tovey, Michael, Gerrard
International Classes:
A61K31/7088; A61K31/7115; A61K31/712; A61K31/7125; A61K38/23; A61K45/00; A61K48/00; A61P7/04; A61P9/00; A61P19/02; A61P21/04; A61P25/00; A61P25/28; A61P31/18; A61P35/00; A61P35/02; A61P43/00; C12N5/10; C12N9/00; C12N15/09; C12N15/113; C12Q1/68; G01N33/566; G01N33/53; G01N33/58; A61K38/00; (IPC1-7): C12N15/09; A61K31/7088; A61K31/7115; A61K31/712; A61K31/7125; A61K38/23; A61K45/00; A61K48/00; A61P7/04; A61P9/00; A61P19/02; A61P21/04; A61P25/00; A61P25/28; A61P31/18; A61P35/00; A61P35/02; A61P43/00; C12N5/10; C12N9/00; C12Q1/68; G01N33/53; G01N33/566; G01N33/58
Attorney, Agent or Firm:
Reiko Tanaka (1 person outside)